US drug approvals
25 approvals with a product on the US market
- Ticagrelor ANDA208508 · approved 28 Oct 2025
- Rivaroxaban ANDA213348 · approved 14 May 2025
- Aripiprazole ANDA213037 · approved 2 Oct 2023
- Metoprolol Succinate ANDA214004 · approved 26 Sep 2022
- Brivaracetam ANDA214748 · approved 9 Jun 2022
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.